|
Volumn 1, Issue 3, 2000, Pages 228-238
|
Locally advanced breast cancer.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
HORMONE;
ADJUVANT CHEMOTHERAPY;
BREAST TUMOR;
CANCER STAGING;
CLINICAL TRIAL;
FEMALE;
HUMAN;
METASTASIS;
MULTIMODALITY CANCER THERAPY;
PROGNOSIS;
RADIOTHERAPY;
REVIEW;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
ANTINEOPLASTIC AGENTS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
COMBINED MODALITY THERAPY;
FEMALE;
HORMONES;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
RADIOTHERAPY;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0034256507
PISSN: 15272729
EISSN: None
Source Type: Journal
DOI: 10.1007/s11864-000-0034-9 Document Type: Review |
Times cited : (16)
|
References (30)
|